- Injective price is up more than 5% in the past 24 hours, reaching an intraday high of $5.85.
- Bulls could push toward $10, but that depends on clearing resistance at $6.
- INJ’s direction will be influenced by broader market trends and key developments on the Injective network.
Injective’s native token is among the altcoins posting gains on December 8, 2025, rising over 5% to an intraday high of $5.85 as investor focus shifts ahead of a significant week for risk assets.
INJ staged a sharp rebound toward $6, a level that acted as resistance on December 4 and has since drawn renewed attention from traders.
This upside move coincides with increased trading activity and growing market interest in projects offering real-world asset (RWA) exposure and improved user experience.
Injective price rises toward $6 amid volume spike
Injective’s price has been in a longer-term downtrend since its all-time high of $52.75 in March 2024. From that peak the token remains sharply lower, and it has also lost roughly 25% over the past month.
Still, recent market strength has supported a bounce from nearby support around $5.
At the time of writing, INJ traded around $5.71, up slightly more than 5% over the previous 24 hours.
Buyers pushed intraday highs to $5.85, flirting with the psychological $6 level. Trading volume jumped to about $67 million, an increase of more than 52% over the last day, underscoring heightened participation.
What’s driving Injective’s gain?
INJ’s rise occurred alongside broader market appreciation, including Bitcoin’s move above $92,000 and Ethereum reclaiming levels above $3,100. This general market lift has likely helped altcoins such as Injective.
Analysts also point to recent integrations and ecosystem upgrades that have increased visibility for Injective. Notably, an integration with DexTools brings real-time asset monitoring exposure to a large user base, which can attract traders and liquidity.
Momentum from Helix, a major decentralized spot and derivatives exchange built within the Injective ecosystem, appears to be another key catalyst. Helix recently rolled out an upgrade enabling gas-free, around-the-clock trading of tokenized stocks, indices, commodities, and FX markets on-chain, broadening the use cases available to traders.
The community has also reacted favorably to governance progress, including approval of an on-chain mechanism for equity pricing, which could help grow real-world asset activity on Injective. Expanded stablecoin deployments and additional RWA initiatives have further supported interest in the network.
INJ price outlook
Although bulls approached $6 during this move, the technical backdrop remains mixed. The longer-term trend has been down, and a renewed broad-market sell-off or failure to clear resistance could limit upside.
The Relative Strength Index (RSI) sits near 44, below the neutral 50 level, but it is trending upward, which suggests growing momentum. The Moving Average Convergence Divergence (MACD) recently printed a bullish crossover but still reflects relatively weak upward momentum.
Near-term price action will likely hinge on whether INJ can decisively break above $6. A sustained move past that level would open targets around $8.22 and then $10. Conversely, if the token falls below roughly $5.05, that would increase downside risk and could lead to further consolidation or declines.
In summary, Injective’s recent uptick reflects both broader crypto market strength and project-specific developments. Traders will watch key technical levels and upcoming network catalysts to gauge whether the rebound can extend toward higher targets or reverts into consolidation.